您的位置: 首页 > 农业专利 > 详情页

CONJUGUÉ D'INSULINE SPÉCIFIQUE AU SITE
专利权人:
HANMI PHARM. CO.; LTD.
发明人:
JANG, MYUNG HYUN,KIM, DAE JIN,HWANG, SANG YOUN,KIM, HYUN UK,JUNG, SUNG YOUB,KWON, SE CHANG
申请号:
EP14757574
公开号:
EP2963055A4
申请日:
2014.02.26
申请国别(地区):
EP
年份:
2016
代理人:
摘要:
Provided are an insulin conjugate having improved insulin receptor binding affinity and increased activity, in which a non-peptidyl polymer and an immunoglobulin Fc region are site-specifically linked to an amino acid residue of the insulin beta chain excluding the N-terminus thereof via a covalent bond, a long-acting formulation including the same, and a preparation method thereof. The insulin conjugate of the present invention is used to provide an insulin formulation which exhibits a remarkably increased in vivo activity of the peptide.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充